This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (339)
Death (57)
Life Threatening Events (8)
Disability (5)
Reports by Reaction Type
Diarrhoea (121),
Malaise (88),
Abdominal Pain (79),
Asthenia (70),
Fatigue (68),
Nausea (68),
Vomiting (60),
Injection Site Pain (58),
Flushing (52),
Blood Pressure Increased (48),
Pain in Extremity (48),
Pain (46)
Below are a few examples of reports where side effects / adverse reactions may be related to Sandostatin (Octreotide). For a complete list or a specific selection of reports, please use the links above.
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Tremor, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Feeling Jittery, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: female
Reactions: Abdominal Pain, Fatigue, Diarrhoea, Arthralgia, Pain in Extremity, Insomnia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, bid
Indication: Acromegaly
Start date: 2009-07-07
Sandostatin LAR
Dosage: 20 mg, monthly
Indication: Acromegaly
Start date: 2009-07-24
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, monthly
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Productive Cough, Contusion, Bone Pain, Chills, Flatulence, Hepatic Lesion, Neoplasm Progression, Constipation, Fall, Faeces Discoloured, Malaise, Road Traffic Accident, Depression, Cough, Ligament Sprain, Defaecation Urgency, Blood Pressure Systolic Increased, Pain in Extremity, Breast Neoplasm, Diarrhoea, Alopecia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Carcinoid Tumour
Start date: 2009-05-21
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Indication: Carcinoid Tumour
Start date: 2009-06-01
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Flushing, Fatigue, Diarrhoea, Pain in Extremity, Pain, Dizziness, Muscle Spasms
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Sandostatin
Dosage: every 12 hrs
Start date: 2012-08-14
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2012-07-04
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2012-07-04
Possible Sandostatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Intestinal Ischaemia, Thrombosis, Abdominal Pain, Lymphadenopathy, Intestinal Obstruction, Intestinal Stenosis, Mucosal Inflammation, Incorrect Drug Administration Duration, Abdominal Distension, Small Intestinal Stenosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Dosage: 2.5mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
End date: 2012-03-01
Atarax
Dosage: 50mg per day
Indication: Product Used FOR Unknown Indication
Codeine Syrup
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Imodium
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Nexium
Dosage: 40mg per day
Indication: Product Used FOR Unknown Indication
Quetiapine
Dosage: 2unit at night
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-02-06
End date: 2012-03-01
Sandostatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Tranxene
Indication: Delirium
Start date: 2012-01-01
End date: 2012-03-01
Other drugs received by patient: Acetaminophen; Flagyl; Acetaminophen; Augmentin '500'; Chlorpromazine HCL; Clozapine; Rocephin; Spasfon; Haloperidol Lactate
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24
Patient: male
Reactions: Intestinal Ischaemia, Blood Iron Decreased, Abdominal Pain, Thrombosis, Lymphadenopathy, Intestinal Obstruction, Gastrointestinal Stenosis, Blood Magnesium Decreased, Transferrin Saturation Decreased, Gastrointestinal Ulcer, Diarrhoea, Colonic Stenosis, Gastrointestinal Disorder, Hypoalbuminaemia, Abdominal Distension, Impaired Gastric Emptying, Small Intestinal Stenosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Start date: 2012-01-01
Arixtra
Dosage: 2.5 mg, daily
Start date: 2012-03-06
End date: 2012-03-01
Atarax
Codeine Syrup
Esomeprazole Sodium
Dosage: 40 mg, daily
Start date: 2012-03-06
Imodium
Dosage: 2 df, tid
End date: 2012-03-01
Imodium
Dosage: 3 df, qid
Start date: 2012-03-06
Quetiapine
Dosage: 600 mg, 1h before the dinner
Start date: 2012-02-06
Quetiapine
Dosage: 600 mg, in the evening
Start date: 2012-03-06
Sandostatin
Start date: 2012-02-01
End date: 2012-03-01
Sandostatin
Dosage: 100 mcg , bid
Start date: 2012-03-06
End date: 2012-03-01
Tranxene
Dosage: 5 mg, in the evening
Start date: 2012-03-06
Tranxene
Dosage: 50 mg, tid
Start date: 2012-01-01
End date: 2012-03-01
Other drugs received by patient: Spasfon; Chlorpromazine HCL; Acetaminophen; Haloperidol Lactate; Augmentin '500'
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient: male
Reactions: Intestinal Ischaemia, Abdominal Pain, Abdominal Distension, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Acetaminophen
Indication: Product Used FOR Unknown Indication
Arixtra
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-01
Arixtra
Start date: 2012-01-27
End date: 2012-03-01
Atarax
Dosage: evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-27
Codeine
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Flagyl
Indication: Product Used FOR Unknown Indication
Imodium
Start date: 2012-02-02
Imodium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-01
Nexium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Quetiapine Fumarate
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-02-06
Quetiapine Fumarate
Administration route: Oral
Start date: 2012-03-06
Rocephin
Indication: Product Used FOR Unknown Indication
Sandostatin
Dosage: 1 in the morning and 1 in the evening
Start date: 2012-03-01
End date: 2012-03-01
Sandostatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Spasfon
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Tranxene
Dosage: in the evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Tranxene
Start date: 2012-01-27
End date: 2012-03-01
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-23
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Cough, Nervousness, Injection Site Mass, Back Pain, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Depressed Mood, Frustration, DRY Eye, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-22
Patient: male
Reactions: Abdominal Pain, Nausea, Blood Pressure Systolic Increased, Flatulence, Gastrointestinal Inflammation, Biliary Colic, Diarrhoea, Dizziness
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Colitis Microscopic
Start date: 2010-10-18
Other drugs received by patient: Budesonide; Lomotil
Possible Sandostatin side effects in male
Reported by a physician from France on 2012-08-21
Patient: male, weighing 87.0 kg (191.4 pounds)
Reactions: Intestinal Ischaemia, Dissociative Disorder, Colitis Ischaemic, Anaemia, Intestinal Obstruction, Delirium, Hypokalaemia, Lung Disorder, Hypomagnesaemia, Hypoalbuminaemia, Suicide Attempt, Septic Shock
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Arixtra
Start date: 2012-01-01
End date: 2012-03-01
Atarax
Clozapine
Dosage: 300 mg to 400 mg per day
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-01-12
End date: 2012-01-19
Codeine Sulfate
Administration route: Oral
Start date: 2012-02-01
End date: 2012-03-01
Imodium
Administration route: Oral
Indication: Diarrhoea
Start date: 2012-02-01
End date: 2012-03-01
Nexium
Administration route: Oral
Sandostatin
Start date: 2012-02-01
End date: 2012-03-01
Seroquel
Dosage: dose progressively increased
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-02-06
End date: 2012-03-05
Tranxene
Administration route: Oral
Indication: Agitation
Start date: 2012-01-27
End date: 2012-03-05
Tranxene
Administration route: Oral
Indication: Anxiety
Start date: 2012-01-27
End date: 2012-03-05
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-20
Patient: male
Reactions: Abdominal Pain, Intestinal Ischaemia, Abdominal Distension, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Arixtra
Start date: 2012-03-06
End date: 2012-03-01
Arixtra
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-27
End date: 2012-03-01
Atarax
Dosage: evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-27
Codeine
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Flagyl
Indication: Product Used FOR Unknown Indication
Imodium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-01
Imodium
Start date: 2012-02-02
Nexium
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Quetiapine Fumarate
Administration route: Oral
Start date: 2012-02-06
Quetiapine Fumarate
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-03-06
Rocephin
Indication: Product Used FOR Unknown Indication
Sandostatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-01
End date: 2012-03-01
Sandostatin
Dosage: 1 in the morning and 1 in the evening
Start date: 2012-03-01
End date: 2012-03-01
Spasfon
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-02
Tranxene
Dosage: in the evening
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
Tranxene
Start date: 2012-01-27
End date: 2012-03-01
Possible Sandostatin side effects in male
Reported by a physician from France on 2012-08-17
Patient: male, weighing 87.0 kg (191.4 pounds)
Reactions: Colitis Ischaemic, Intestinal Ischaemia, Dissociative Disorder, Anaemia, Intestinal Obstruction, Delirium, Hypokalaemia, Lung Disorder, Hypomagnesaemia, Hypoalbuminaemia, Suicide Attempt, Septic Shock
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Arixtra
Start date: 2012-01-01
End date: 2012-03-01
Atarax
Clozapine
Dosage: 300 mg to 400 mg per day
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-01-12
End date: 2012-01-19
Codeine Sulfate
Administration route: Oral
Start date: 2012-02-01
End date: 2012-03-01
Imodium
Administration route: Oral
Indication: Diarrhoea
Start date: 2012-02-01
End date: 2012-03-01
Nexium
Administration route: Oral
Sandostatin
Start date: 2012-02-01
End date: 2012-03-01
Seroquel
Dosage: dose progressively increased
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-02-06
End date: 2012-03-05
Tranxene
Administration route: Oral
Indication: Agitation
Start date: 2012-01-27
End date: 2012-03-05
Tranxene
Administration route: Oral
Indication: Anxiety
Start date: 2012-01-27
End date: 2012-03-05
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-17
Patient: female
Reactions: Death, Abdominal Pain, Confusional State, Neoplasm Malignant, Diarrhoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Sandostatin
Start date: 2012-06-01
Sandostatin LAR
Dosage: 30 mg, monthly
Indication: Neuroendocrine Tumour
Start date: 2012-06-29
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Dyspnoea, Disorientation, Discomfort, Blood Glucose Decreased, Abdominal Discomfort, Flushing, Diarrhoea, Blood Glucose Fluctuation, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Sandostatin LAR
Dosage: 20 mg, (every 2 weeks)
Other drugs received by patient: Lantus; Novorapid
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Germany on 2012-08-16
Patient: male
Reactions: Diabetes Mellitus, Drug Intolerance
Drug(s) suspected as cause:
Sandostatin
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Jaundice, Abdominal Pain, Blood Bilirubin Increased, Confusional State, Agitation, Weight Decreased, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Malaise, Fatigue, Pleural Effusion, Cardiac Failure Congestive, Cough, Decreased Appetite, Lethargy, Blood Pressure Increased, Dyspnoea, Restlessness, Pain in Extremity, Ascites, Discomfort, Heart Rate Decreased, Abdominal Mass, Syncope, Micturition Disorder, Joint Swelling, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Other drugs received by patient: Sutent
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-16
Patient: female
Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Thermal Burn, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Gastrinoma
Start date: 2010-06-10
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Gastrinoma
Start date: 2010-06-21
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, qmo
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-14
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Blood Pressure Systolic Increased, Suffocation Feeling, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Cough, Blood Pressure Diastolic Decreased, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2011-07-15
Other drugs received by patient: Dicyclomine; Bisoprolol; Metoprolol
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-13
Patient: female
Reactions: Death, Fatigue, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Crohn's Disease
Sandostatin
Dosage: 500 ug, bid
Indication: Neoplasm Malignant
Start date: 2012-06-28
Sandostatin LAR
Dosage: 20 mg once a month
Indication: Neoplasm Malignant
Start date: 2012-06-28
End date: 2012-06-28
Sandostatin LAR
Indication: Crohn's Disease
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-13
Patient: female
Reactions: Nausea, Blood Pressure Decreased
Drug(s) suspected as cause:
Sandostatin
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-10
Patient: male
Reactions: Haemorrhage, Hypotension, Tachycardia, Malaise, Postoperative Wound Infection, Pleural Effusion, Bone Disorder, Septic Shock, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 ug, tid
Indication: Haemorrhage
Sandostatin LAR
Dosage: 30 mg, once a month
Indication: Haemorrhage
Start date: 2012-06-20
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-10
Patient: female
Reactions: Central Nervous System Inflammation, Demyelination, Paraesthesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-10
Patient: female
Reactions: Diarrhoea, Nausea, Hypotension, Headache
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Blinded Som230
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin LAR
Dosage: 40 mg, qmo (every 4 weeks)
Indication: Metastatic Carcinoid Tumour
Start date: 2009-07-06
End date: 2011-12-13
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-07
Patient: male
Reactions: Tachycardia, Hypotension, Wound Secretion, Occult Blood Positive, Malaise, Pulmonary Oedema, Bone Disorder, Septic Shock, Asthenia, TOE Amputation, Post Procedural Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 ug, tid
Indication: Haemorrhage
Sandostatin LAR
Dosage: 30 mg, once a month
Indication: Haemorrhage
Start date: 2012-06-20
Possible Sandostatin side effects in female
Reported by a physician from United States on 2012-08-07
Patient: female, weighing 69.3 kg (152.5 pounds)
Reactions: Cardio-Respiratory Arrest, Post Procedural Complication, Pneumothorax, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Everolimus (Afiitor, RAD-001)
Dosage: 150 mg
End date: 2012-07-12
Sandostatin
Dosage: 20 mg
End date: 2012-07-20
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-07
Patient: female
Reactions: Large Intestine Perforation, Drug Ineffective, Urinary Tract Infection, Iatrogenic Injury, Intestinal Obstruction, Foot Fracture, Postoperative Wound Infection, Diarrhoea, Dehydration, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, bid
Indication: Crohn's Disease
Start date: 2010-01-01
Sandostatin
Dosage: 100 ug, bid
Start date: 2010-02-01
Sandostatin LAR
Dosage: 30 mg, once a month
Indication: Crohn's Disease
Start date: 2010-07-29
End date: 2010-08-31
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Start date: 2010-10-18
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 20 mg, tiw
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-07
Patient: female
Reactions: Fatigue, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 500 ug, bid
Indication: Neoplasm Malignant
Start date: 2012-06-28
Sandostatin
Indication: Crohn's Disease
Sandostatin LAR
Indication: Crohn's Disease
Sandostatin LAR
Dosage: 20 mg once a month
Indication: Neoplasm Malignant
Start date: 2012-06-28
End date: 2012-06-28
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-06
Patient: male
Reactions: Blood Bilirubin Increased, Confusional State, Weight Decreased, Abdominal Pain, Agitation, Jaundice, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Fatigue, Malaise, Pleural Effusion, Cough, Decreased Appetite, Lethargy, Cardiac Failure Congestive, Blood Pressure Increased, Dyspnoea, Pain in Extremity, Restlessness, Discomfort, Ascites, Syncope, Abdominal Mass, Heart Rate Decreased, Joint Swelling, Micturition Disorder, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Other drugs received by patient: Sutent
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-06
Patient: female
Reactions: Nausea, Diarrhoea, Hypotension, Headache
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Blinded Som230
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin LAR
Dosage: 40 mg, qmo (every 4 weeks)
Indication: Metastatic Carcinoid Tumour
Start date: 2009-07-06
End date: 2011-12-13
|
